NCI Definition: A benign or malignant, primary or metastatic neoplasm of the bladder. - 2003 
Bladder neoplasms most frequently harbor alterations in TP53, KDM6A, KMT2D, FGFR3, and ARID1A .
TP53 Mutation, TP53 Missense, TP53 c.217-c.1178 Missense, FGFR3 Mutation, and KMT2D Mutation are the most common alterations in bladder neoplasm .
There is 1 clinical trial for bladder neoplasm, of which 0 are open and 1 is completed or closed. Of the trial that contains bladder neoplasm as an inclusion criterion, 1 is no phase specified (0 open).
Continuous bladder irrigation and surgery are the most common interventions in bladder neoplasm clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.